APA (7th ed.) Citation

Mehra, T., Lupatsch, J. E., Koessler, T., Dedes, K., Siebenhüner, A. R., Moos, R. v., . . . Schwenkglenks, M. E. Correction: Olaparib not cost-effective as maintenance therapy for platinum-sensitive, BRCA1/2 germline-mutated metastatic pancreatic cancer. Public Library of Science (PLoS).

Chicago Style (17th ed.) Citation

Mehra, Tarun, Judith E. Lupatsch, Thibaud Koessler, Konstantin Dedes, Alexander Reinhard Siebenhüner, Roger von Moos, Andreas Wicki, and Matthias E. Schwenkglenks. Correction: Olaparib Not Cost-effective as Maintenance Therapy for Platinum-sensitive, BRCA1/2 Germline-mutated Metastatic Pancreatic Cancer. Public Library of Science (PLoS).

MLA (9th ed.) Citation

Mehra, Tarun, et al. Correction: Olaparib Not Cost-effective as Maintenance Therapy for Platinum-sensitive, BRCA1/2 Germline-mutated Metastatic Pancreatic Cancer. Public Library of Science (PLoS).